SRI/Surgical Express (STRC)
SRI/Surgical Express R&D Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
STRC R&D Expense Rankings
| Overall | 99th percentile | 13 of 1762 |
| Sector | 98th percentile | 3 of 195 in Services |
| Industry | 0th percentile | 1 of 1 in Medical Equipment Wholesale |
STRC R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.00 | Jun 2007 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these STRC related companies
STRC News
$STRC forms bullish "Bottom Triangle" chart pattern. http://stks.co/3qUe
about 17 days ago by RecogniaEvents
about 17 days ago by RecogniaEvents
$STRC forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3W8Y
about 37 days ago by RecogniaEvents
about 37 days ago by RecogniaEvents
$STRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Fft
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
SRI/Surgical Express, Inc. (STRC) Reports Q4 EPS of $0.04; Continues Exploring Alternatives
Mar 26, 4:18PM Street Insider
Mar 26, 4:18PM Street Insider
Trading Radar for 03/26: Reed's (REED), Tengion (TNGN), Landex (LNDC), KIOR (KIOR) Report
Mar 23, 3:48PM Street Insider
Mar 23, 3:48PM Street Insider
SRI/Surgical Express, Inc. Announces Fourth Quarter 2011 Conference Call
Mar 19, 5:00PM Business Wire
Mar 19, 5:00PM Business Wire
SRI Surgical pursues strategic alternatives, alliance, merger, or sale possible
Sep 14, 5:30PM FlyOnTheWall
Sep 14, 5:30PM FlyOnTheWall
Investors push SRI/Surgical Express ($STRC) to explore strategic alternatives. http://bit.ly/hCZJIh http://bit.ly/gaVqVl
about 540 days ago by GeoffGannon
about 540 days ago by GeoffGannon
$STRC for entertainment check out last night's cc those were some unhappy holders and uncomfortable mngmt as wouldn't discuss offer for co
about 567 days ago by Detroitblues
about 567 days ago by Detroitblues
$STRC trading very nicely on news of interested parties.My guess as to potential acquirer $CAH.Should be interesting e/r due Thursday
about 571 days ago by Detroitblues
about 571 days ago by Detroitblues
$STRC traded above $5 in April and $4.5 in June so if I can buy in the $3.40 range knowing an offer is out there I like the risk reward
about 571 days ago by Detroitblues
about 571 days ago by Detroitblues
$STRC like this tiny medical supply company announce Friday unsolicited offer by a large firm.Adopted poison pill.Offer will surface
about 571 days ago by Detroitblues
about 571 days ago by Detroitblues
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| STRC | 3.51 | -0.04 | -1.13% | 22.82M |
| STRA | 86.87 | -2.98 | -3.32% | 1.066B |
| STR | 19.76 | -0.30 | -1.52% | 3.571B |
| STPZ | 53.55 | -0.12 | -0.22% | |
| STP | 1.59 | -0.06 | -3.64% | 297.26M |
| STON | 24.64 | -0.46 | -1.83% | 486.19M |
| STO | 22.26 | -0.44 | -1.94% | 72.38B |
| STNR | 44.55 | -1.28 | -2.79% | 699.37M |
| STNG | 5.42 | -0.17 | -3.04% | 214.38M |
| STN | 28.54 | -1.82 | -5.99% | 1.383B |
